Ignite Creation Date:
2024-05-06 @ 10:58 AM
Last Modification Date:
2024-10-26 @ 12:38 PM
Study NCT ID:
NCT03397680
Status:
UNKNOWN
Last Update Posted:
2018-05-01
First Post:
2017-09-09
Brief Title:
Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia
Sponsor:
Thammasat University
Organization:
Thammasat University
Study Overview
Official Title:
Effectiveness of Once-daily Dose Regimen of 7-day and 14-day High Dose Rabeprazole-levofloxacin Based Quadruple Therapy for H Pylori Eradication in Thai Patients With Non-ulcer Dyspepsia
Status:
UNKNOWN
Status Verified Date:
2018-04
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hpylori is an organism which causes gastric inflammation peptic ulcer disease PUD mucosa associated lymphoid tissue MALT lymphoma and gastric cancer
Practical guideline for treatment of patients with dyspepsia and Hpylori eradication recommended the 14-day triple therapy regimen which had curable about 70 by using proton pump inhibitor PPI combined with antibiotics including amoxicillin clarithromycin and metronidazole
Up to date there has been no evidence about the cure rate for Hpylori eradication with once-daily dose regimen of high dose rabeprazole and levofloxacin based therapy This research is to study the 7-day and 14-day cure rate of Hpylori eradication treatment with once-daily regimen of high dose rabeprazole-levofloxacin based quadruple therapy
Practical guideline for treatment of patients with dyspepsia and Hpylori eradication recommended the 14-day triple therapy regimen which had curable about 70 by using proton pump inhibitor PPI combined with antibiotics including amoxicillin clarithromycin and metronidazole
Up to date there has been no evidence about the cure rate for Hpylori eradication with once-daily dose regimen of high dose rabeprazole and levofloxacin based therapy This research is to study the 7-day and 14-day cure rate of Hpylori eradication treatment with once-daily regimen of high dose rabeprazole-levofloxacin based quadruple therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None